日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome

伊达比星、阿糖胞苷和普伐他汀作为未经治疗的急性髓系白血病和高危骨髓增生异常综合征的诱导治疗

Shadman, Mazyar; Mawad, Raya; Dean, Carol; Chen, Tara L; Shannon-Dorcy, Kathleen; Sandhu, Vicky; Hendrie, Paul C; Scott, Bart L; Walter, Rol B; Becker, Pamela S; Pagel, John M; Estey, Elihu H